Just eight days after signing a U.S. House Republican letter supporting a “robust 340B rebate model pilot,” a Mississippi congressman [...] …
Pharma Industry
Exclusive
Novo Nordisk Says it Won’t Require Tennessee Providers to Report Claims Data Following AG Warning
A major drugmaker recently told a Tennessee official that it will not require state providers to submit 340B claims data [...] …
Please Login or Become a Paid Subscriber to View this Content
A Brussels-based drugmaker recently became the seventh manufacturer to announce an expansion of its 340B claims data requirements to in-house pharmacy use, while a Chicago-based pharmaceutical giant updated its contract pharmacy restrictions to exempt Washington state covered entities.
UCB informed
…
Multiple 340B providers have recently received letters from Eli Lilly warning they could lose access to 340B pricing unless they [...] …
Please Login or Become a Paid Subscriber to View this Content
A New Orleans federal appeals court recently denied a major pharmaceutical manufacturer’s request to reconsider a ruling in favor of [...] …
Please Login or Become a Paid Subscriber to View this Content
Louisiana Attorney General Liz Murrill (R) recently told a national legal news service that her office is preparing enforcement actions [...] …
Please Login or Become a Paid Subscriber to View this Content
Washington D.C.’s most powerful drug industry trade group launched a new ad Wednesday accusing 340B hospitals of profiting off “medicine [...] …
Please Login or Become a Paid Subscriber to View this Content
A California-based drugmaker this week announced new contract pharmacy restrictions for covered entities looking to purchase a low blood sugar [...] …
Please Login or Become a Paid Subscriber to View this Content
Two economists with previous ties to a pharmaceutical industry-funded patient advocacy group recently argued that classifying 340B as a tax [...] …
Please Login or Become a Paid Subscriber to View this Content
Gilead Latest Drugmaker to Move to Truzo, Kalderos’ Platform for 340B Contract Pharmacy Restrictions
A California-based drugmaker recently announced that it will become the fourth drugmaker to utilize a new platform for its 340B [...] …